Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Oncologist|June 28, 2017
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 ResultsSibylle Loibl, Nicholas C Turner, Jungsil Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trialOtto Metzger-Filho, Marion Procter, Evandro de Azambuja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancerCatherine L Harper-Wynne, Nigel P M Sacks, Karyn Shenton, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2017
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2John M S Bartlett, Ikhlaaq Ahmed, Meredith M Regan, et al.
Human Pathology|September 28, 2015
"Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoringJesse A Engelberg, Hanna Retallack, Ronald Balassanian, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapyTengfei Xiao, Wei Li, Xiaoqing Wang, et al.
Archives of Pathology & Laboratory Medicine|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Embryonic transcription factor SOX9 drives breast cancer endocrine resistanceRinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Cell Reports|January 28, 2014
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversityVanessa Almendro, Yu-Kang Cheng, Amanda Randles, et al.
Pageof 5